BJPsych Advances最新文献

筛选
英文 中文
Consent in minors: the differential treatment of acceptance and refusal. Part 1 Autonomy and children's rights 未成年人的同意:接受与拒绝的区别对待。第1部分自治与儿童权利
IF 1.3
BJPsych Advances Pub Date : 2023-06-05 DOI: 10.1192/bja.2023.23
T. Hawkins, M. Curtice, Tom Adams
{"title":"Consent in minors: the differential treatment of acceptance and refusal. Part 1 Autonomy and children's rights","authors":"T. Hawkins, M. Curtice, Tom Adams","doi":"10.1192/bja.2023.23","DOIUrl":"https://doi.org/10.1192/bja.2023.23","url":null,"abstract":"\u0000 This is the first of two articles reviewing consent in those under the age of 18 (also referred to as ‘minors’ in UK law). This can be a complex issue in clinical practice because the law endows competent/capacitated minors with the absolute right to accept treatment, but a limited right to refuse. This first article summarises recent cases of refusal of treatment in minors. It uses them to ask two central questions: how do we, as clinicians, think about autonomous self-determination in minors and to what extent does the rights agenda support minors’ autonomous self-determination? Autonomy as one of the principles of biomedical ethics is explored. How the minors’ rights agenda supports the development of autonomy is considered. The amount of weight given in the domestic courts to the rights of minors with reference to the Human Rights Act 1998 and the United Nations Convention on the Rights of the Child is described. These considerations demonstrate the way that the courts are giving the views of the minor greater weight in decision-making in keeping with age and maturity. This article introduces the second article, which comprehensively reviews decision-making in minors, explores competence and capacity in minors and examines the differential treatment of acceptance and refusal.","PeriodicalId":9336,"journal":{"name":"BJPsych Advances","volume":"61 1","pages":""},"PeriodicalIF":1.3,"publicationDate":"2023-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73822441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychotropic medication for problem behaviours in intellectual disability and autism spectrum disorder: the need for caution 智力残疾和自闭症谱系障碍问题行为的精神药物治疗:需要谨慎
IF 1.3
BJPsych Advances Pub Date : 2023-05-15 DOI: 10.1192/bja.2023.22
M. Bertelli
{"title":"Psychotropic medication for problem behaviours in intellectual disability and autism spectrum disorder: the need for caution","authors":"M. Bertelli","doi":"10.1192/bja.2023.22","DOIUrl":"https://doi.org/10.1192/bja.2023.22","url":null,"abstract":"SUMMARY Many persons with intellectual developmental disorders and/or autism spectrum disorder presenting problem behaviours undergo pharmacotherapy without receiving an appropriate psychiatric assessment and diagnosis. Instead, prescription of psychotropic medication should have specific aims and involve interdisciplinary assessment, personalisation and patient and family participation. Current knowledge about pharmacological management of problem behaviours in this population is limited, necessitating extreme caution in clinical practice and more research into the complex interrelated factors that affect presentation, course and treatment response.","PeriodicalId":9336,"journal":{"name":"BJPsych Advances","volume":"13 1","pages":"334 - 336"},"PeriodicalIF":1.3,"publicationDate":"2023-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85219482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Managing epilepsy in people with intellectual disabilities – creating capable communities 管理智力残疾者的癫痫——创建有能力的社区
IF 1.3
BJPsych Advances Pub Date : 2023-04-28 DOI: 10.1192/bja.2023.19
R. Shankar
{"title":"Managing epilepsy in people with intellectual disabilities – creating capable communities","authors":"R. Shankar","doi":"10.1192/bja.2023.19","DOIUrl":"https://doi.org/10.1192/bja.2023.19","url":null,"abstract":"SUMMARY Almost a quarter of people with intellectual disabilities have epilepsy. This life-long condition adversely affects their health, safety and well-being and carries an increased risk of sudden unexpected death in epilepsy (SUDEP) in this population. This commentary considers what not only health and social services but also communities and people with intellectual disabilities themselves can do to improve outcomes.","PeriodicalId":9336,"journal":{"name":"BJPsych Advances","volume":"13 1","pages":"305 - 307"},"PeriodicalIF":1.3,"publicationDate":"2023-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84102995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Aripiprazole for autism spectrum disorders (ASD), a Cochrane Review 阿立哌唑治疗自闭症谱系障碍(ASD), Cochrane综述
IF 1.3
BJPsych Advances Pub Date : 2023-04-26 DOI: 10.1192/bja.2023.15
Lauren Hirsch, T. Pringsheim
{"title":"Aripiprazole for autism spectrum disorders (ASD), a Cochrane Review","authors":"Lauren Hirsch, T. Pringsheim","doi":"10.1192/bja.2023.15","DOIUrl":"https://doi.org/10.1192/bja.2023.15","url":null,"abstract":"Autism spectrum disorders (ASD) include autistic disorder, Asperger’s disorder and pervasive developmental disorder not otherwise specified (PDD-NOS). Antipsychotics have been used as a medication intervention for irritability related to ASD. Aripiprazole, a third-generation, atypical antipsychotic, is a relatively new drug that has a unique mechanism of action different from that of other antipsychotics. This review updates a previous Cochrane review on the safety and efficacy of aripiprazole for individuals with ASD, published in 2011 (Ching 2011).","PeriodicalId":9336,"journal":{"name":"BJPsych Advances","volume":"17 1","pages":"289 - 289"},"PeriodicalIF":1.3,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83310429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Aripiprazole in autism spectrum disorder: current evidence for use 阿立哌唑治疗自闭症谱系障碍:目前使用的证据
IF 1.3
BJPsych Advances Pub Date : 2023-04-26 DOI: 10.1192/bja.2022.77
A. Bunting, Harriet Feldman
{"title":"Aripiprazole in autism spectrum disorder: current evidence for use","authors":"A. Bunting, Harriet Feldman","doi":"10.1192/bja.2022.77","DOIUrl":"https://doi.org/10.1192/bja.2022.77","url":null,"abstract":"SUMMARY This month's Cochrane Corner meta-analysis evaluates the evidence for the use of aripiprazole in ‘autism spectrum disorders’ – although in fact, outcome measures mainly included subtypes of challenging behaviour and side-effects. Aripiprazole was found to be effective in reducing irritability and hyperactivity, while causing extrapyramidal side-effects and weight gain. Only three trials were included in the review, with two small trials eventually included in the meta-analysis. All trials were conducted in under-18s in the USA, with no requirement for a trial of behavioural management before psychotropic medication, and excluding under-18s with important comorbidities such as medicated attention-deficit hyperactivity disorder. All three studies were sponsored and funded by the manufacturer of aripiprazole. Further, a discontinuation trial showed no evidence of sustained benefit beyond 16 weeks of treatment.","PeriodicalId":9336,"journal":{"name":"BJPsych Advances","volume":"29 1","pages":"290 - 294"},"PeriodicalIF":1.3,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82471136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
New from CPD eLearning CPD在线学习的新内容
IF 1.3
BJPsych Advances Pub Date : 2023-04-25 DOI: 10.1192/bja.2023.18
{"title":"New from CPD eLearning","authors":"","doi":"10.1192/bja.2023.18","DOIUrl":"https://doi.org/10.1192/bja.2023.18","url":null,"abstract":"CPD credits: 0.5 Podcast Coping, resilience and surviving trauma In this podcast Dr Raj Persaud talks to Dr Vajrin Malin about the immediate psychological impact of a sudden physical trauma, the importance of having goals and a sense of purpose when faced with challenges and how trainee doctors who may be struggling to cope with stress or trauma can be supported.","PeriodicalId":9336,"journal":{"name":"BJPsych Advances","volume":"266 1","pages":"167 - 167"},"PeriodicalIF":1.3,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76397604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BJA volume 29 issue 3 Cover and Front matter BJA第29卷第3期封面和封面问题
IF 1.3
BJPsych Advances Pub Date : 2023-04-25 DOI: 10.1192/bja.2023.20
{"title":"BJA volume 29 issue 3 Cover and Front matter","authors":"","doi":"10.1192/bja.2023.20","DOIUrl":"https://doi.org/10.1192/bja.2023.20","url":null,"abstract":"","PeriodicalId":9336,"journal":{"name":"BJPsych Advances","volume":"1 1","pages":"f1 - f1"},"PeriodicalIF":1.3,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80050563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BJA volume 29 issue 3 Cover and Back matter BJA第29卷第3期封面和封底
IF 1.3
BJPsych Advances Pub Date : 2023-04-25 DOI: 10.1192/bja.2023.21
{"title":"BJA volume 29 issue 3 Cover and Back matter","authors":"","doi":"10.1192/bja.2023.21","DOIUrl":"https://doi.org/10.1192/bja.2023.21","url":null,"abstract":"","PeriodicalId":9336,"journal":{"name":"BJPsych Advances","volume":"16 1","pages":"b1 - b1"},"PeriodicalIF":1.3,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82703448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacotherapy for post traumatic stress disorder (PTSD), a Cochrane Review 创伤后应激障碍(PTSD)的药物治疗,Cochrane综述
IF 1.3
BJPsych Advances Pub Date : 2023-04-25 DOI: 10.1192/bja.2023.17
T. Williams, N. Phillips, D. Stein, J. Ipser
{"title":"Pharmacotherapy for post traumatic stress disorder (PTSD), a Cochrane Review","authors":"T. Williams, N. Phillips, D. Stein, J. Ipser","doi":"10.1192/bja.2023.17","DOIUrl":"https://doi.org/10.1192/bja.2023.17","url":null,"abstract":"Data collection and analysis Three review authors (TW, JI, and NP) independently assessed RCTs for inclusion in the review, collated trial data, and assessed trial quality. We contacted investigators to obtain missing data. We stratified summary statistics by medication class, and by medication agent for all medications. We calculated dichotomous and continuous measures using a random-effects model, and assessed heterogeneity.","PeriodicalId":9336,"journal":{"name":"BJPsych Advances","volume":"87 1","pages":"168 - 168"},"PeriodicalIF":1.3,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76132558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medication choice in post-traumatic stress disorder 创伤后应激障碍的药物选择
IF 1.3
BJPsych Advances Pub Date : 2023-04-25 DOI: 10.1192/bja.2023.16
Heidi Cooper
{"title":"Medication choice in post-traumatic stress disorder","authors":"Heidi Cooper","doi":"10.1192/bja.2023.16","DOIUrl":"https://doi.org/10.1192/bja.2023.16","url":null,"abstract":"SUMMARY Post-traumatic stress disorder is a disabling condition resulting from a range of traumas and affecting many people worldwide. This month's Cochrane Corner review systematically searched and reported findings from 66 randomised controlled trials of pharmacotherapy for PTSD, 54 of which were included in a meta-analysis. Evidence was shown for the benefit of selective serotonin reuptake inhibitors, mirtazapine and amitriptyline in treatment response. This Round the Corner commentary critically appraises the review's findings, concluding that the summative evidence was of poor quality owing to the low number of studies, the high risk of bias and significant heterogeneity.","PeriodicalId":9336,"journal":{"name":"BJPsych Advances","volume":"166 1","pages":"169 - 176"},"PeriodicalIF":1.3,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90978108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信